Article info
PDFEditorial commentary
Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?
- Correspondence to Mia van der Kop, Epidemiologist, University of British Columbia Centre for Disease Control, Doctoral student, Department of Public Health Sciences, Karolinska Institutet, 655 12th Avenue West, Vancouver, British Columbia, Canada V57 4R4; miavanderkop{at}gmail.com
Citation
Does antiretroviral therapy for HIV reduce the risk of developing multiple sclerosis?
Publication history
- Received June 2, 2014
- Revised June 3, 2014
- Accepted June 4, 2014
- First published August 4, 2014.
Online issue publication
June 29, 2021
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions